AVOS Life Sciences is a boutique advisory and research products firm headquartered in Research Triangle Park, NC with offices in New York and New Jersey. We specialize in developing and maintaining leading edge understanding of the evolving healthcare environment and helping clients position themselves to win in the future.
AVOS has recently released TMO Reports on Obesity, Asthma/COPD, Diabetes, Antidepressants, and Lipid Modulating Agents. We define our success by offering clients value through taking on high impact issues and providing actionable recommendations.
Our insight and guidance is supplied through a series of research products that focus on key strategic issues and through consulting engagements structured to work closely with client teams to respond to their specific needs. Our intent is to build a knowledge rich organization that has its foundations in collaboration and learning.
Meet our senior staff.
What's New
AVOS announces the latest Therapeutic Market Outlook (TMO) Report on Multiple Sclerosis is available to its subscription customers and is available for purchase by nonsubscribers through this website.
In addition, AVOS has recently updated the market model included in the TMO Report on Diabetes released in October 2007. The update reflects the withdrawal and termination of inhaled insulin products. The update also includes an expanded table of compounds in Phase II and III development, and several other key events impacting the type 2 diabetes market.
